A clinical trial to study the effect and safety of the Siddha medicines in patients with Corona Virus disease
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/07/026471
- Lead Sponsor
- The Directorate of Indian Medicine and Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
COVID -19 Positive as determined by RT-PCR or other approved commercial or public health assay
Willing to provide written/digital informed consent.
COVID - 19 Positive with no clinical signs
COVID - 19 Positive with mild symptoms â?? Fever, Cough, Sneezing, Sore Throat, Throat Pain, Malaise, Tiredness
Pregnant and lactating females
COVID - 19 Positive with Severe symptoms â?? Respiratory distress ( >24 breath per minute), Oxygen saturation <90% at rest, Respiratory failure, Need of Mechanical Ventilation, Septic shock, Non-respiratory organ failure
Chronic Renal Failure requiring dialysis (eGFR < 30)
Known cases of uncontrolled Diabetes ( >10% HbA1c)
Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening
Subjects having immune-compromised status like HIV, Hepatitis, Tuberculosis, Cancer, etc.
Participants taking Steroid treatment and or any kind of immunosuppressive therapy
Participants participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.
Participants having a past history of allergy to Siddha medicine.
Participants with Hb - <7 g/d
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method